Posted by Gary Schwitzer in Health care journalism
I’m on 3 panels at the Association of Health Care Journalists annual conference this week in Seattle. 
Friday at 11 a.m.: Explaining costs in health care stories.
Friday at 3:15 pm: State legislation encouraging shared decision-making. Clinical, policy, legal views in one session.
Saturday at 2:30 p.m.: “How To Report on Studies” workshop. This session will mark the first time that the original publishers of the Australian, Canadian and US teams that have graded more than 2,000 health care stories will appear together on the same panel. It’s Dr. David Henry – now in Toronto – who was the pioneer with the Media Doctor Australia website, Alan Cassels of the University of Victoria who started the Media Doctor Canada website, and me – publisher of the HealthNewsReview.org website. Should be fun.
Comments are closed.
Treatment for advanced ovarian tumors may lengthen survival, but questions still remain, despite the story’s emphasis on “promising” and “new hope.”
As with the HealthDay story on this research that we reviewed, readers of this story get a good dose of caveats and cautions along with the suggestions that electrical brain stimulation might someday “have implications” for treatment of Alzheimer’s disease.
The readers of this story and the other one we reviewed by Reuters are likely to understand that electrical brain stimulation could have some memory effects, but it’s a long way from becoming a treatment for Alzheimer’s disease.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2012 Health News Review
